Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SWIM: Ibuprofen for Acute Pain in Sickle Cell Disease
NCT00880373Phase 4Terminated
- Sponsor
- London North West University Healthcare NHS Trust
- Start
- Mar 2011
- Primary completion
- Mar 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in sickle cell disease (SCD) comparing Ibuprofen + Opioid with Placebo + Opioid (2 arms). Primary endpoint: Patient controlled analgesia (PCA) diamorphine or morphine consumption at 4 days. Started Mar 2011; status: terminated.
02
Drugs
ibuprofen
03
Conditions
sickle cell disease (SCD)
Beyond the preview
Go deeper on NCT00880373.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00880373.